adimmune corporation
Adimmune To Begin Phase III Flu Vaccine Trials In China
Taiwanese vaccine maker Adimmune Corp has received approval from the Chinese government to start Phase III clinical trials of its flu vaccine in China.
Taiwan Vaccine Maker Completes PhIII Trials On H7N9 Influenza Vaccine
Taiwan-based vaccine maker Adimmune Corp says that it has the capacity to produce up to three million units per month of its preliminary H7N9 influenza vaccine.
